Funding

............- Regulation of Signaling by mGluR5
............- Muscarinic receptor activators as novel antipsychotic agents

............- Functions of Metabotropic Glutamate Receptor Subtype
............- Metabotropic Glutamate Receptors in Basal Ganglia
............- mGluR4 Potentiators as a Treatment for Parkinson's Disease

............- Vanderbilt Screen Center- GPCRs, Ion Channels, and ...
............- Vanderbilt Screen Center- GPCRs, Ion Channels, and ...